Antimicrobial Resistance and Virulence – 3rd Volume
A special issue of Antibiotics (ISSN 2079-6382).
Deadline for manuscript submissions: closed (31 March 2023) | Viewed by 46202
Special Issue Editors
2. Associate Laboratory for Animal and Veterinary Sciences (AL4AnimalS), 1300-477 Lisboa, Portugal
3. Centre for Ecology, Evolution and Environmental Changes (cE3c) & Global Change and Sustainability Institute (CHANGE), Faculty of Sciences, University of Lisbon, Campo Grande, 1749-016 Lisboa, Portugal
Interests: one health; clinical bacteriology; biofilms; antimicrobial resistance; wildlife bacteriology; mycology; bacterial virulence; genomics; infections pathogenesis; food safety
Special Issues, Collections and Topics in MDPI journals
Interests: animal reproduction; bacterial infections; host–bacterial interactions; molecular biology; genomics
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The use of antibiotics for the treatment of infectious diseases began in the 1940s with penicillin. In spite of their unquestionable contribution to the decline of morbidity and mortality rates in both human and veterinary medicine, antibiotics administration prompted the emergence and dissemination of multiresistant bacterial strains. This phenomenon represents a major concern for Public and Animal Health worldwide and has instigated the development of a new generation of antibiotics. However, these new molecules soon became ineffective due to the capability of bacteria to evolve, in particular through mutations or horizontal gene transfer.
Global dissemination of resistant bacteria, in particular to last-resource antibiotics, has been referred to as the next pandemic. In 2017, the World Health Organization (WHO) has published a list of antimicrobial-resistant "priority pathogens" for which new therapeutic solutions are urgent, which include a group of microorganisms with high level resistance to multiple drugs, named ESKAPE pathogens, comprising of vancomycin resistant Enterococcus faecium (VRE), methicillin and vancomycin resistant Staphylococcus aureus (MRSA and VRSA), extended spectrum β-lactamase (ESBL) or carbapenem resistant Klebsiella pneumoniae, carbapenem resistant Acinetobacter baumannii, carbapenem resistant Pseudomonas aeruginosa and extended spectrum β-lactamase (ESBL) or carbapenem resistant Enterobacter spp.
These bacteria also have the ability to produce several virulence factors, which have a major influence on infectious disease outcome. In fact, some virulence factors, such as biofilm-producing ability and others, contribute to an increased resistance ability. Surveillance of important resistant and virulent clones is of major relevance for the establishment of control measures to be applied to the prevention of infections promoted by these strains in both human and veterinary medicine, and is also relevant to address the role of natural environments in the circulation of these strains.
This Special Issue constitutes a Third Volume focusing on Antimicrobial Resistance and Virulence, and aims to publish manuscripts that further clarify on the impact of bacterial antimicrobial resistance and virulence in the three areas of the One Health triad, i.e., animal, human, and environmental health.
Dr. Manuela Oliveira
Dr. Elisabete Silva
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antimicrobial resistance
- bacterial virulence
- biofilms
- epidemiology
- genomics
- infections pathogenesis
- One Health
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.